Niagen Bioscience Inc. (NAGE)
Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
3. 13
0
0%
After Hours
$
+0.12 +3.8339% 3. 25
- Market Cap
- P/E Ratio
- Div Yield
282,951 Volume
- Eps
$ 3.13
Previous Close Want to track NAGE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
NAGE closed today higher at $3.13, an increase of 0% from yesterday's close, completing a monthly decrease of -10.5714% or -$0.37. Over the past 12 months, NAGE stock lost -51.0938%.
NAGE is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, missed the consensus estimates by -0.0533%. On average, the company has fell short of earnings expectations by -0.0159%, based on the last three reports.
Niagen Bioscience Inc. has completed 1 stock splits, with the recent split occurring on Apr 13, 2016.
The company's stock is traded on one exchange.
NAGE Chart
Niagen Bioscience, Inc. (NAGE) Q2 2026 Earnings Call Transcript
Niagen Bioscience, Inc. (NAGE) Q2 2026 Earnings Call Transcript
Seekingalpha | 3 weeks ago
Niagen Bioscience (NAGE) Meets Q2 Earnings Estimates
Niagen Bioscience (NAGE) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.04 per share a year ago.
Zacks | 3 weeks ago
Niagen Bioscience, Inc. (NAGE) Discusses Strategic Expansion Into Pharmaceutical Development and NB4168 Drug Program Transcript
Niagen Bioscience, Inc. (NAGE) Discusses Strategic Expansion Into Pharmaceutical Development and NB4168 Drug Program Transcript
Seekingalpha | 1 month ago
Niagen Bioscience Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 749 | $3,690.72 | $2,217.04 | -$1,473.68 | -39.93% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 800 | $2,640 | $2,464 | -$176 | -6.67% |
| BG Bart Gancher Intech Investment Management LLC | 14,463 | $173,337.56 | $45,124.56 | -$128,213 | -73.97% |
| KAC Kimberly A. Clarke Stoneridge Investment Partners LLC | 14,477 | $92,051.78 | $42,851.92 | -$49,199.86 | -53.45% |
| JM John Malone Amundi | 12,748 | $42,068.4 | $38,881.4 | -$3,187 | -7.58% |
Niagen Bioscience Inc. (NAGE) FAQ
What is the stock price today?
The current price is $3.13.
On which exchange is it traded?
Niagen Bioscience Inc. is listed on NASDAQ (CM).
What is its stock symbol?
The ticker symbol is NAGE.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Niagen Bioscience Inc. ever had a stock split?
Niagen Bioscience Inc. had 1 splits and the recent split was on Apr 13, 2016.
